Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Invest in 50+ Global Mutual Funds
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Diversify into RBI-regulated P2P lending platforms and earn up to 11.5% p.a.
Invest in curated
corporate, gold, and govt. bonds
Earn income
while helping India move to clean energy
Connect with investors, share insights, and grow together.
Master the world of Alternative Investments with our in-depth courses
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning.
Read about our journey and get to know the leadership team at Vested
The fund employs a passive management - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials. more
Time Frame | SBIO | S&P500 |
---|---|---|
1-Week Return | 1.74% | 1.86% |
1-Month Return | -1.69% | 6.39% |
3-Month Return | -6.86% | -0.73% |
6-Month Return | -25.42% | -2.29% |
1-Year Return | -13.23% | 12.88% |
3-Year Return | 13.59% | 42.84% |
5-Year Return | -29.52% | 93.02% |
10-Year Return | -13.8% | 179.63% |
Time Frame | SBIO | S&P500 |
---|---|---|
1-Week Return | 145.83% | 161.42% |
1-Month Return | -18.73% | 112.47% |
3-Month Return | -25.04% | -2.93% |
6-Month Return | -44.83% | -4.59% |
1-Year Return | -13.23% | 12.88% |
3-Year Return | 4.34% | 12.62% |
5-Year Return | -6.76% | 14.06% |
10-Year Return | -1.47% | 10.83% |
Stock name | Ticker | Weight |
---|---|---|
| VRNA | 5.6% |
| ALKS | 4.2% |
| AXSM | 4.06% |
| RYTM | 3.43% |
| MRUS | 3.39% |
| PTCT | 3.36% |
| AKRO | 3.34% |
| RNA | 3.32% |
| ACAD | 3.19% |
| ZLAB | 2.86% |
Sector | Weight |
---|---|
Health care | 100.00% |
ALPS Medical Breakthroughs ETF (SBIO) share price today is $29.1318.
Yes, Indians can buy shares of ALPS Medical Breakthroughs ETF (SBIO) on Vested. To buy SBIO from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of ALPS Medical Breakthroughs ETF (SBIO) on Vested. You can start investing in ALPS Medical Breakthroughs ETF (SBIO) with a minimum investment of $1.
The 52-week high price of ALPS Medical Breakthroughs ETF (SBIO) is $41.27. The 52-week low price of ALPS Medical Breakthroughs ETF (SBIO) is $22.33.
The stock symbol (or ticker) of ALPS Medical Breakthroughs ETF is SBIO.
Yes, you can setup SIP in ALPS Medical Breakthroughs ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of SBIO on the Vested app.
You can also access the top holdings, the expense ratio, and the sector breakdown for ALPS Medical Breakthroughs ETF on Vested.
The expense ratio of ALPS Medical Breakthroughs ETF (SBIO) is 0.5%.